Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 81277-81278 [2010-32421]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 247 / Monday, December 27, 2010 / Notices
erowe on DSK5CLS3C1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Bryan Saddler, Chief Counsel, FHFA–
OIG, at (202) 408–2577, or
Bryan.Saddler@fhfa.gov.
SUPPLEMENTARY INFORMATION: The
Federal Housing Finance Regulatory
Reform Act of 2008 (Reform Act), which
was passed as Division A of the Housing
and Economic Recovery Act of 2008
(HERA), Public Law 110–289, 122 Stat.
2654, 2913, abolished both the Federal
Housing Finance Board (FHFB), an
independent agency that oversaw the
Federal Home Loan Banks (Banks), and
the Office of Federal Housing Enterprise
Oversight (OFHEO), an office within the
Department of Housing and Urban
Development (HUD) that oversaw the
‘‘safety and soundness’’ of Fannie Mae
and Freddie Mac. See 12 U.S.C. 1422a,
4502(6), 4511, 4512, 4513, 4541, 4563
(2006); H.R. Rep. No. 110–142, at 95.
The Reform Act established in place of
the FHFB and OFHEO a new entity, the
Federal Housing Finance Agency
(FHFA), which now regulates and
supervises Fannie Mae, Freddie Mac,
and the 12 Banks. See Reform Act
sections 1002, 1101, 1102, 1301, 1311;
12 U.S.C.A. 4511, 4512, 4513 (2009).
Section 1105 of HERA also amended
the Federal Housing Enterprises
Financial Safety and Soundness Act of
1992 and the Inspector General Act of
1978 (the IG Act), by specifying that
there shall be established an Inspector
General within FHFA. See 12 U.S.C.
4517(d). FHFA–OIG is responsible for,
among other things, conducting audits,
investigations, and inspections of
FHFA’s programs and operations, and
recommending polices that promote
economy and efficiency in the
administration of, and prevent and
detect fraud and abuse in, those
programs and operations. Section 6(a)(4)
of the IG Act authorizes the Inspector
General to require by subpoena the
production of all information,
documents, reports, answers, records,
accounts, papers, and other data and
documentary evidence deemed
necessary in the performance of the
Inspector General’s function. This
notice delegates the Inspector General’s
subpoena issuance authority to the
FHFA–OIG Principal Deputy Inspector
General, the FHFA–OIG Deputy
Inspector General for Audit, the FHFA–
OIG Deputy Inspector General for
Investigations & Evaluations, and the
FHFA–OIG Chief Counsel.
Section 552a(b)(7) of Title 5, United
States Code, authorizes the Inspector
General to request information protected
by the Privacy Act for a civil or criminal
law enforcement activity. This notice
delegates this authority to request
VerDate Mar<15>2010
15:15 Dec 23, 2010
Jkt 223001
records protected by the Privacy Act for
a civil or criminal law enforcement
activity from the Inspector General to
the FHFA–OIG Principal Deputy
Inspector General, the FHFA–OIG
Deputy Inspector General for Audit, the
FHFA–OIG Deputy Inspector General
for Investigations & Evaluations, and the
FHFA–OIG Chief Counsel.
The Inspector General has not limited
his authority to issue subpoenas or to
request information under 5 U.S.C. 552a
by this delegation. Also, this delegation
expressly prohibits further delegation or
redelegation.
Accordingly, the Inspector General
delegates the following authorities:
Section A. Authority Delegated: The
Inspector General delegates to the
FHFA–OIG Principal Deputy Inspector
General, the FHFA–OIG Deputy
Inspector General for Audit, the FHFA–
OIG Deputy Inspector General for
Investigations & Evaluations, and the
FHFA–OIG Chief Counsel, the authority
to require by subpoena the production
of all information, documents, reports,
answers, records, accounts, papers, and
other data and documentary evidence
necessary in the performance of the
functions assigned by HERA and the
Inspector General Act.
Additionally, the Inspector General
delegates to the FHFA–OIG Principal
Deputy Inspector General, the FHFA–
OIG Deputy Inspector General for Audit,
the FHFA–OIG Deputy Inspector
General for Investigations & Evaluations,
and the FHFA–OIG Chief Counsel, the
authority to request information under 5
U.S.C. 552a(b)(7).
Section B. No Further Delegation or
Redelegation: The authority delegated in
Section A above may not be further
delegated or redelegated.
Authority: Pub. L. 110–289, section 1105;
5 U.S.C. App. 3 § 6(a)(4); 5 U.S.C. 301.
Dated: December 14, 2010.
Steve A. Linick,
Inspector General.
[FR Doc. 2010–32348 Filed 12–23–10; 8:45 am]
BILLING CODE 8070–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
81277
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date:
11 a.m.–2 p.m., January 12, 2011
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
Status: Open to the public, but without a
public comment period.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines, which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
most recently, August 3, 2009, and will
expire on August 3, 2011.
Purpose: This Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The agenda for the
conference call includes: NIOSH 10-Year
Review of its Division of Compensation
Analysis and Support (DCAS) Program;
Linde Ceramics Plant SEC Petition #107
(1954–2006); DCAS Science Issues Update;
Subcommittee and Work Group Updates;
DCAS SEC Petition Evaluations Update for
the February 2011 Advisory Board Meeting;
and Board Correspondence.
The agenda is subject to change as
priorities dictate.
Because there is not a public comment
period, written comments may be submitted.
Any written comments received will be
included in the official record of the meeting
E:\FR\FM\27DEN1.SGM
27DEN1
81278
Federal Register / Vol. 75, No. 247 / Monday, December 27, 2010 / Notices
and should be submitted to the contact
person below in advance of the meeting.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton Road
NE., Mailstop: E–20, Atlanta, GA 30333,
Telephone (513) 533–6800, Toll Free 1–800–
CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: December 20, 2010.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2010–32421 Filed 12–23–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–6041–NC]
Medicare Program: Solicitation of
Comments Regarding Development of
a Recovery Audit Contractor Program
for the Medicare Part C and D
Programs
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Request for information.
AGENCY:
This notice presents an
approach and requests comments on the
provision of the Patient Protection and
Affordable Care Act (Pub. L. 111–148),
as amended by the Health Care and
Education Reconciliation Act of 2010
(Pub. L. 111–152), (collectively known
as The Affordable Care Act (ACA)) that
requires the expansion of the Recovery
Audit Contractor (RAC) Program to the
Medicare Part C and D programs.
DATES: Comment Date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
February 25, 2011.
ADDRESSES: In commenting, please refer
to file code CMS–6041–NC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
four ways (please choose only one of the
ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
erowe on DSK5CLS3C1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:15 Dec 23, 2010
Jkt 223001
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–6041–NC, P.O. Box 8013,
Baltimore, MD 21244–8013.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services
Department of Health and Human
Services, Attention: CMS–6041–NC,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
4. By hand or courier. Alternatively,
you may deliver (by hand or courier)
your written comments only to one of
the following addresses prior to the
close of the comment period: a. For
delivery in Washington, DC—Centers
for Medicare & Medicaid Services
Department of Health and Human
Services, Room 445–G, Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
(Because access to the interior of the
Hubert H. Humphrey Building is not
readily available to persons without
Federal government identification,
commenters are encouraged to leave
their comments in the CMS drop slots
located in the main lobby of the
building. A stamp-in clock is available
for persons wishing to retain a proof of
filing by stamping in and retaining an
extra copy of the comments being filed.)
b. For delivery in Baltimore, MD—
Centers for Medicare & Medicaid
Services Department of Health and
Human Services, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
If you intend to deliver your
comments to the Baltimore address, call
(410) 786–9994 in advance to schedule
your arrival with one of our staff
members.
Comments erroneously mailed to the
addresses indicated as appropriate for
hand or courier delivery may be delayed
and received after the comment period.
Submission of comments on
paperwork requirements. You may
submit comments on this document’s
paperwork requirements by following
the instructions at the end of the
‘‘Collection of Information
Requirements’’ section in this document.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Cynthia Moreno (410) 786–1164.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following Web
site as soon as possible after they have
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will also
be available for public inspection as
they are received, generally beginning
approximately three weeks after
publication of a document, at the
headquarters of CMS, 7500 Security
Boulevard, Baltimore, Maryland 21244,
Monday through Friday of each week
from 8:30 a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Background
The Balanced Budget Act of 1997
(BBA) (Pub. L. 105–33) established the
Medicare+Choice (M+C) program.
Under section 1851(a)(1) of the Social
Security Act (the Act), every individual
with Medicare Parts A and B, except for
individuals with end stage renal
disease, could elect to receive benefits
either through the original Medicare
program or an M+C plan, if one was
offered where the beneficiary lived. The
primary goal of the M+C program was
to provide Medicare beneficiaries with a
wider range of health plan choices.
The Medicare, Medicaid, and SCHIP
Balanced Budget Refinement Act of
1999, (Pub. L. 106–113), amended the
M+C provisions of the BBA. Further
amendments were made to the M+C
program by the Medicare, Medicaid, and
SCHIP Benefits Improvement and
Protection Act of 2000 (Pub. L. 106–
554), enacted December 21, 2000.
On December 8, 2003, the Congress
enacted the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173). Title I
of the MMA added new sections 1860D–
1 through 1860D–42 to the Act creating
the Medicare Prescription Drug Benefit
(Part D) program, a landmark change to
the Medicare program.
Sections 201 through 241 of Title II of
the MMA made significant changes to
the M+C program. As directed by Title
II of the MMA, we renamed the M+C
program the Medicare Advantage (MA)
program. We also revised our
regulations to include new payment and
bidding provisions based largely on risk,
to recognize the addition of regional
Preferred Provider Organization plans,
to address the provision of prescription
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 75, Number 247 (Monday, December 27, 2010)]
[Notices]
[Pages 81277-81278]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32421]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date:
11 a.m.-2 p.m., January 12, 2011
Place: Audio Conference Call via FTS Conferencing. The USA toll-
free, dial-in number is 1-866-659-0537 and the pass code is 9933701.
Status: Open to the public, but without a public comment period.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines,
which have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, most recently, August 3,
2009, and will expire on August 3, 2011.
Purpose: This Advisory Board is charged with (a) Providing
advice to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advising the Secretary on whether there is a class
of employees at any Department of Energy facility who were exposed
to radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class.
Matters to be Discussed: The agenda for the conference call
includes: NIOSH 10-Year Review of its Division of Compensation
Analysis and Support (DCAS) Program; Linde Ceramics Plant SEC
Petition 107 (1954-2006); DCAS Science Issues Update;
Subcommittee and Work Group Updates; DCAS SEC Petition Evaluations
Update for the February 2011 Advisory Board Meeting; and Board
Correspondence.
The agenda is subject to change as priorities dictate.
Because there is not a public comment period, written comments
may be submitted. Any written comments received will be included in
the official record of the meeting
[[Page 81278]]
and should be submitted to the contact person below in advance of
the meeting.
Contact Person for More Information: Theodore M. Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road NE., Mailstop: E-
20, Atlanta, GA 30333, Telephone (513) 533-6800, Toll Free 1-800-
CDC-INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Dated: December 20, 2010.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2010-32421 Filed 12-23-10; 8:45 am]
BILLING CODE 4163-18-P
